Trial NCT01464593

View at ClinicalTrials.gov 
Org. Study IDs: 104-10-201

Last trial update was posted on 2022-10-13

MeSH Interventions

Doxorubicin Liposomal doxorubicin

MeSH Conditions

Colonic Neoplasms Neoplasm Metastasis

Other Conditions

Colon Cancer Liver Metastasis

Stopping Reasons

trial design contingent on RFA optimization

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID